US Stock MarketDetailed Quotes

JANX Janux Therapeutics

Watchlist
  • 47.100
  • -1.110-2.30%
Close Apr 25 16:00 ET
  • 47.200
  • +0.100+0.21%
Post 17:22 ET
2.43BMarket Cap-35681P/E (TTM)

About Janux Therapeutics Company

Janux Therapeutics, Inc. operates preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in La Jolla, CA.

Company Profile

SymbolJANX
Company NameJanux Therapeutics
Listing DateJun 11, 2021
Issue Price17.00
Founded2017
CEODr. David Campbell, PhD
MarketNASDAQ
Employees64
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address11099 North Torrey Pines Park,Suite 290
CityLa Jolla
ProvinceCalifornia
CountryUnited States of America
Zip Code92037
Phone1-858-750-4700
Websitehttp://www.januxrx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. David Campbell, PhD
  • Director, President and Chief Executive Officer
  • 6.00M
  • Tighe Reardon
  • Acting Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Byron Robinson
  • Chief Strategy Officer
  • 3.37M
  • Andy Meyer
  • Chief Business Officer
  • --
  • Dr. Jay Lichter, PhD
  • Chairman of the Board
  • 161.17K
  • Dr. Ronald W. Barrett,PhD
  • Director
  • 131.17K
  • Dr. Sheila Gujrathi, M.D.
  • Director
  • 131.17K
  • Alana B. McNulty
  • Independent Director
  • 135.27K
  • Winston Kung, M.B.A.
  • Independent Director
  • 384.93K
  • Vickie L. Capps
  • Independent Director
  • 146.17K
  • Dr. Jake Sin, PhD
  • Independent Director
  • 144.17K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg